MedPath

nani treatment for heavy menstrual bleeding

Phase 2
Completed
Conditions
Health Condition 1: N924- Excessive bleeding in the premenopausal period
Registration Number
CTRI/2022/02/040084
Lead Sponsor
ational Institute of Unani Medicine
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1. MBL >80 ml with estimated PBAC score >100.

2. Age group of 18-40 years.

Exclusion Criteria

Women with-

1. Known cases of systemic diseases like thyroid dysfunction, diabetes mellitus, hypertension and malignancies.

2. Severe anemia and known cases of bleeding disorders.

•History of hormonal contraceptives in last 3 months.

•Known cases of Endometriosis, uterine polyps , fibroid >3cm and >3 in number.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Changes in PBAC scoreTimepoint: baseline, monthly for 3 months
Secondary Outcome Measures
NameTimeMethod
Changes in MAUS score, USG pelvis, Hb%.Timepoint: baseline, monthly for 3 months and post trail
© Copyright 2025. All Rights Reserved by MedPath